Do more with Oracle Argus. 24th Sep 2013 Oracle Open World, SFO. Confidential Information . This document contains information that is confidential and proprietary to Infosys Limited. No part of it may be used, circulated, quoted, or reproduced for distribution outside Infosys Limited.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
24th Sep 2013
Oracle Open World, SFO
This document contains information that is confidential and proprietary to Infosys Limited. No part of it may be used, circulated, quoted, or reproduced for distribution outside Infosys Limited.
Any disclosure of confidential information to, or use of it by a third party will be damaging to Infosys. The ownership of all confidential information no matter what media it resides in, remains with Infosys.
Views and points expressed in this document are based on Infosys experience working on Oracle Argus Safety Applications
Ram Krishna Prasad
Oracle Life Sciences Practice @Infosys
Proposed Idea / Solution
Benefits of the Solution
Q & A
Skill sets: Life Sciences (LS) Consultants
Breadth : Offers broad range of Services
Our Solutions: Presented in Oracle Open World -2012
Alliance with Oracle
Predictability : Creating success stories
A fully functional lab with all the Oracle LS products installed, configured and integrated. The following applications are up & running in our Life Sciences lab.
Clinical Trial Data Applications
Clinical Warehouse & Analytics
Clinical Development Center (CDC)
Life Sciences Data Hub
Clinical Analytics (CDA)
Life Sciences COE Lab on Infosys Cloud
Universal content Management
This research provides an opportunity to utilize the Oracle Argus Drug Safety Application for medical and scientific research in addition to Pharmacovigilance.
Drug Research and Sales-Distribution Process
Wish I have a Unified place to have all the information??...
Sales Channels Influencers
Other Sources (internet, books and journals etc..)
Investment in Marketing
Scattered Product Information
Vast and Complex Data
Lack of comparative Product Details
High Lead time in sharing the product Info.
Providing best medical treatment options
The PV data should be used for educating Health Care Professionals & Research Scholar’s to improve safe drug utilization & research process.
This can be achieved by developing an extension to Argus Safety Application
Leveraging the following information from Argus
a). Product details
b). Patient details
c). Event details
New Web Based Interface
Flexibility, Filtering options
MedDRA, WHO Drug Dictionaries
Data from UMC/Regulatory Database/Other Sources
The solution is based on leveraging capabilities of Argus Safety and Argus Insight modules from Oracle
PV data stored in Argus safety for a Pharma client is transferred to Argus Insight through ETL .
PV data of other companies obtained from Regulatory bodies / Other sources will be loaded into Argus Insight
Argus Insight dashboards to be used to provide information to internal sales and research teams
Web Based user interface to be created for outside agencies like HCP’s.
This interactive interface will help HCP get information on drug composition, comparisons, dosage and forms available.
User friendly reports to help them get the following
The solution is expected to take 60 person months of effort and is estimated at a one time cost of 450K USD depending upon the complexity of client landscape
Broader Data Security/Regulatory concerns
Application Integrity (ETL)
Education to Application User
Need to develop online CBT/ application user manual
Medical and Scientific research Community
Health Care provider
By extending ARGUS Safety, this solution would ensure pharma clients to stay at the forefront by providing timely product information to HCP’s, analyzing latest trends and usage of the product.
In addition, this would influence the pharmaceutical industries to use ARGUS Safety as a commercial application.
If you have any questions, please contact